Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 6:13:100456.
doi: 10.1016/j.ijcchd.2023.100456. eCollection 2023 Sep.

Systemic hypertension in adults with congenital heart diseases

Jolanda Sabatino  1   2 , Martina Avesani  1   2 , Domenico Sirico  1   2 , Elena Reffo  1   2 , Biagio Castaldi  1   2 , PierPaolo Bassareo  3 , Giovanni Di Salvo  1   2
Affiliations
Review

Systemic hypertension in adults with congenital heart diseases

Jolanda Sabatino et al. Int J Cardiol Congenit Heart Dis. .

Abstract

Long-term effects of systemic hypertension (HTN) and HTN-mediated damages have been largely studied in non-congenital adult populations. By contrast, robust data about the predisposing factors, prevalence, consequences, and treatment of HTN in adults with congenital heart diseases (ACHD) is still scarce. Different mechanisms including the underlying cardiac disease, cardiac surgery and its consequences, the development of metabolic syndrome and secondary forms seem to play a role in HTN in ACHDs. To mitigate the potential long-term effects of HTN in this complex population, a meticulous follow-up is mandatory to identify patients who should receive treatment, and tailored strategies should be applied to obtain the best as possible result. Thus, this review will investigate risk factors, effects, and treatments of HTN in ACHD patients.

Keywords: Systemic hypertension-congenital heart disease-adults.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Classification of Hypertension Grades.
See this image and copyright information in PMC

References

    1. Williams B., Mancia G., Spiering W., et al. ESC scientific document group. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018 Sep 1;39(33):3021–3104. doi: 10.1093/eurheartj/ehy339. - DOI - PubMed
    1. de Simone G., Mancusi C., Hanssen H., et al. Hypertension in children and adolescents. Eur Heart J. 2022 Sep 14;43(35):3290–3301. doi: 10.1093/eurheartj/ehac328. PMID: 35896123. - DOI - PubMed
    1. Bauer U.M.M., Körten M.A., Diller G.P., et al. Cardiovascular risk factors in adults with congenital heart defects - recognised but not treated? An analysis of the German National Register for Congenital Heart Defects. Int J Cardiol. 2019 Feb 15;277:79–84. doi: 10.1016/j.ijcard.2018.08.009. - DOI - PubMed
    1. Flannery L.D., Fahed A.C., DeFaria Yeh D., et al. Frequency of guideline-based statin therapy in adults with congenital heart disease. Am J Cardiol. 2018 Feb 15;121(4):485–490. doi: 10.1016/j.amjcard.2017.11.009. - DOI - PubMed
    1. Roche S.L., Silversides C.K. Hypertension, obesity, and coronary artery disease in the survivors of congenital heart disease. Can J Cardiol. 2013 Jul;29(7):841–848. doi: 10.1016/j.cjca.2013.03.021. - DOI - PubMed

LinkOut - more resources